Stocks and Investing
Stocks and Investing
Tue, August 9, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Ed Arce Maintained (AUPH) at Strong Buy with Decreased Target to $26 on, Aug 9th, 2022
Ed Arce of HC Wainwright & Co., Maintained "Aurinia Pharmaceuticals Inc." (AUPH) at Strong Buy with Decreased Target from $30 to $26 on, Aug 9th, 2022.
Ed has made no other calls on AUPH in the last 4 months.
There are 3 other peers that have a rating on AUPH. Out of the 3 peers that are also analyzing AUPH, 0 agree with Ed's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Ed
- Justin Kim of "Oppenheimer" Maintained at Buy with Decreased Target to $13 on, Monday, August 8th, 2022
- Olivia Brayer of "Cantor Fitzgerald" Initiated at Buy and Held Target at $25 on, Thursday, May 5th, 2022
- Douglas Miehm of "RBC Capital" Maintained at Buy with Decreased Target to $22 on, Thursday, April 28th, 2022
Contributing Sources